Navigation auf uzh.ch

Suche

Faculty of Law Chair Vokinger

Prof. Dr. iur. et Dr. med. Kerstin Noëlle Vokinger, LL.M.

Double Professor University of Zurich & ETH Zurich - Academic Chair for Regulation in Law, Medicine and Technology

 

Professorship ETH Zürich (https://vokinger.ethz.ch/)

Affiliated Faculty PORTAL (Program on Regulation, Therapeutics, and Law), Harvard Medical School (https://www.portalresearch.org)

Faculty Associate, Berkman Klein Center for Internet & Society, Harvard University (https://cyber.harvard.edu)


University of Zurich
Faculty of Law
Rämistrasse 74/37, 8001 Zurich
Office: RAI G 053

Consultation: By agreement
Phone: +41 44 634 49 86 (Office Management)
Email: Lst.vokinger@ius.uzh.ch

 

News

September 2024

Professor Kerstin Noëlle Vokinger featured in NZZ am Sonntag

Article

Professor Kerstin Noëlle Vokinger has been appointed as Professor (Extraordinaria) at the Department of Health Sciences and Technology at the ETH Zurich (double professorship with the University of Zurich). Our Academic Chair in Regulation in Law, Medicine, and Technology will be affiliated at the ETH Zurich and the University of Zurich starting 1 October 2024. 

ETH News

Portal of the Swiss government

June 2024

Professor Kerstin Noëlle Vokinger testified before the Parliament of the Federal Republic of Germany ("Deutscher Bundestag") during a hearing on the pricing of medicines.

Parliament - media library

List of experts

April 2024

Professor Kerstin Noëlle Vokinger advised in the revision of the procedures for updating WHO's Model Lists of Essential Medicines. The consultation report  "Revising the procedures for updating WHO's Model Lists of Essential Medicines: Consultation report" has been published.  

https://iris.who.int/bitstream/handle/10665/376543/9789240091696-eng.pdf?sequence=1 

June 2023

Professor Kerstin Noëlle Vokinger was appointed to the Cancer Medicines Committee of the European Society of Medical Oncologogy (ESMO). 

https://www.esmo.org/about-esmo/organisational-structure/cancer-medicines-committee

June 2023

Professor Kerstin Noëlle Vokinger was appointed to the Senate of the Swiss Academy of Medical Science (SAMW). 

September 2022

Professor Kerstin Noëlle Vokinger has been awarded with the Swiss Science Prize Latsis 2022. The price is awarded annually to a young researcher up to the age of 40. In her research activities in the fields of law, medicine and technology, Professor Vokinger has wide-ranging professional interaction and applies interdisciplinary methodological approaches that are currently unique in Switzerland. She combines traditional legal and medical analyses with empirical data evaluations and also draws on expertise in artificial intelligence and machine learning. Kerstin Noëlle Vokinger has developed a distinctive research profile within a very short time. The topics she deals with are of relevance to science and society.

More information:

Swiss Science Prizes Marcel Benoist and Latsis go to pioneer in laser physics and innovative legal and medical scholar

Uniquely interdisciplinary: Kerstin Vokinger wins Swiss Science Prize Latsis

 

More

Grants

Swiss National Science Foundation (SNSF)

SNSF

Swiss Cancer Research Foundation (Krebsforschung Schweiz)

KF

University of Zurich Digital Society Initiative

uzh

Kaiser Permanent Institute for Health Policy

ihp

 

Advising activities (selection)

Federal Office for Public Health (FOPH)
bag
Federal Departement of Foreign Affairs (FDFA) eda
Agencies of the United Nations
un

 

Weiterführende Informationen

Ausgewählte Publikationen

Determinants of cancer drug pricing and how to overcome the cancer premium

More about Determinants of cancer drug pricing and how to overcome the cancer premium
Publication

Sources of Innovation in Gene Therapies — Approaches to Achieving Affordable Prices. NEJM 2023.

WHO shapes priorities for medicines? An analysis of the applicants and decision makers within the historical evolution of the WHO Model Lists of Essential Medicines

Time From Approval to Reimbursement of New Drugs: A Comparative Analysis Between the United States, England, Germany, France, and Switzerland (2011–2022)

Publication

Reforming the World Health Organization's Essential Medicines List. Essential but Unaffordable. JAMA 2022.

Publication JAMA

Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis. The Lancet Ocology 2022.

NMI

Regulating AI in medicine in the United States and Europe. Nature Machine Intelligence 2021.

Publication

Analysis of launch and postapproval cancer drug pricing, clinical benefit, and policy implications in the US and Europe. JAMA Oncology 2021.

Publication

Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. Lancet Digital Health 2021.

Publication JAMA

Clinical benefit of cancer drugs and prices in the US and Europe. Lancet Ocology 2020.

Publication JAMA

Lifecycle regulation of artificial intelligence- and machine learning based software devices in medicine. JAMA 2019.

Beitrag Jusletter

Re-Identifikation von Gerichtsurteilen durch "Linkage" von Daten(banken). Eine empirische Analyse anhand von Bundesgerichtsbeschwerden gegen (Preissfestsetzungs-) Verfügungen von Arzneimitteln. Jusletter 2019.

Social media

To the Website of the Faculty of Law

Data Protection

The UZH uses the Matomo software to compile access statistics. Details about data protection at UZH can be found here
More about safe surfing can be foundhere

Social media